No CrossRef data available.
Article contents
Predictive Models of Metabolic Syndrome for Patients with Schizophrenic or Bipolar Disorders
Published online by Cambridge University Press: 16 April 2020
Abstract
Metabolic syndrome is a frequent, severe, undiagnosed physical comorbidity in patients with severe mental disorders.
To develop a predictive model of metabolic syndrome for patients with schizophrenic or bipolar disorders, useful for both clinical practice and research.
Naturalistic, one-year follow-up study conducted in Asturias, Spain. A total of 172 patients with schizophrenic (Sch-P) or bipolar (BD-P) disorders (ICD-10 criteria), under maintenance treatment, who gave written informed consent were included. Metabolic syndrome was defined according to the modified NCEP ATP-III criteria. Multivariate Adaptive Regression Splines (MARS), Genetic Algorithms (GA), and Support Vector Machine (SVM) analysis were performed.
Starting from a large set of demographic and clinical variables, and by means of intermediate MARS and GA models, an SVM model able to classify if a patient with schizophrenia or bipolar disorder suffers from metabolic syndrome with an accuracy of 98.68% (sensitivity 100%, specifity 94.4%) was obtained. The final model only needs 6 variables: Sch-P:
(1) Low HDL-cholesterol,
(2) Fasting glucose level,
(3) Family history of obesity,
(4) Triglyceride level,
(5) Family history of dyslipidemia, and
(6) Use of antidepressants; BD-P: (1), (2), (3),
(7) Use of lipid-lowering medication,
(8) Use of antipsychotics, and
(9) Use of mood stabilizers.
We developed a simple and easy to use predictive model to identify metabolic syndrome in patients with schizophrenic or bipolar disorders.
- Type
- P03-222
- Information
- European Psychiatry , Volume 26 , Issue S2: Abstracts of the 19th European Congress of Psychiatry , March 2011 , pp. 1391
- Copyright
- Copyright © European Psychiatric Association 2011
Comments
No Comments have been published for this article.